Search Results - Svendsen, S.L.

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    WS04.03 Elexacaftor/tezacaftor/ivacaftor (ETI) treatment corrects the salt-losing phenotype in people with cystic fibrosis (pwCF)

    WS04.03 Elexacaftor/tezacaftor/ivacaftor (ETI) treatment corrects the salt-losing phenotype in people with cystic fibrosis (pwCF) by Berg, P., Svendsen, S.L., Sørensen, M.V., Rousing, A.Q., Jensen-Fangel, S., Warth, R., Bandulik, S., Jeppesen, M., Leipziger, J.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: